tiprankstipranks
Cardiol Therapeutics Inc. (CRDL)
:CRDL
US Market

Cardiol Therapeutics (CRDL) Income Statement

Compare
362 Followers

Cardiol Therapeutics Income Statement

Last quarter (Q3 2024), Cardiol Therapeutics's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, Cardiol Therapeutics's net income was C$-12.73M. See Cardiol Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ ―C$ ―C$ ―C$ ―C$ ―
Gross Profit
C$ ―C$ ―C$ ―C$ ―C$ ―
Operating Expenses
C$ ―C$ ―C$ ―C$ ―C$ ―
Depreciation and Amortization
C$ ―C$ 219.91KC$ ―C$ 229.54KC$ 150.57K
EBITDA
C$ -27.88MC$ -36.23MC$ -38.44MC$ -20.46MC$ -13.53M
Operating Income
C$ -29.79MC$ -41.34MC$ -38.66MC$ -20.69MC$ -14.13M
Other Income/Expenses
C$ ―C$ ―C$ ―C$ ―C$ ―
Pretax Income
C$ ―C$ ―C$ ―C$ ―C$ ―
Net Income
C$ -28.13MC$ -36.45MC$ -31.64MC$ -20.64MC$ -13.68M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ ―C$ ―C$ ―C$ ―C$ ―
Diluted EPS
C$ ―C$ ―C$ ―C$ ―C$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis